-
2
-
-
34248683583
-
Chemoprevention of breast cancer for women at high risk
-
Chan K and Morris GJ: Chemoprevention of breast cancer for women at high risk. Semin Oncol 33: 642-646, 2006.
-
(2006)
Semin Oncol
, vol.33
, pp. 642-646
-
-
Chan, K.1
Morris, G.J.2
-
3
-
-
0038011249
-
Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis
-
Shimada K, Nakamura M, Ishida E, Kishi M and Konishi N: Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis 24: 1067-1075, 2003.
-
(2003)
Carcinogenesis
, vol.24
, pp. 1067-1075
-
-
Shimada, K.1
Nakamura, M.2
Ishida, E.3
Kishi, M.4
Konishi, N.5
-
4
-
-
33947381796
-
Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione
-
Fan Y, Chen H, Qiao B, et al: Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione. Mol Cells 23: 30-38, 2007.
-
(2007)
Mol Cells
, vol.23
, pp. 30-38
-
-
Fan, Y.1
Chen, H.2
Qiao, B.3
-
5
-
-
0034644522
-
Signal transduction by the JNK group of MAP kinases
-
Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252, 2000.
-
(2000)
Cell
, vol.103
, pp. 239-252
-
-
Davis, R.J.1
-
6
-
-
0034607702
-
Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
-
Tournier C, Hess P, Yang D, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA and Davis RJ: Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870-874, 2000.
-
(2000)
Science
, vol.288
, pp. 870-874
-
-
Tournier, C.1
Hess, P.2
Yang, D.3
Xu, J.4
Turner, T.K.5
Nimnual, A.6
Bar-Sagi, D.7
Jones, S.N.8
Flavell, R.A.9
Davis, R.J.10
-
7
-
-
33646133216
-
UVA/B-induced apoptosis in human melanocytes involves translocation of cathepsins and Bcl-2 family members
-
Bivik CA, Larsson PK, Kågedal KM, Rosdahl IK and Öllinger KM: UVA/B-induced apoptosis in human melanocytes involves translocation of cathepsins and Bcl-2 family members. J Invest Dermatol 126: 1119-1127, 2006.
-
(2006)
J Invest Dermatol
, vol.126
, pp. 1119-1127
-
-
Bivik, C.A.1
Larsson, P.K.2
Kågedal, K.M.3
Rosdahl, I.K.4
Öllinger, K.M.5
-
8
-
-
12144291516
-
JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways
-
Dietrich N, Thastrup J, Holmberg C, Gyrd-Hansen M, Fehrenbacher N, Lademann U, Lerdrup M, Herdegen T, Jäättelä M and Kallunki T: JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways. Cell Death Differ 11: 301-313, 2004.
-
(2004)
Cell Death Differ
, vol.11
, pp. 301-313
-
-
Dietrich, N.1
Thastrup, J.2
Holmberg, C.3
Gyrd-Hansen, M.4
Fehrenbacher, N.5
Lademann, U.6
Lerdrup, M.7
Herdegen, T.8
Jäättelä, M.9
Kallunki, T.10
-
9
-
-
0030920914
-
The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin
-
Potapova O, Haghighi A, Bost F, Liu C, Birrer MJ, Gjerset R and Mercola D: The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J Biol Chem 272: 14041-14044, 1997.
-
(1997)
J Biol Chem
, vol.272
, pp. 14041-14044
-
-
Potapova, O.1
Haghighi, A.2
Bost, F.3
Liu, C.4
Birrer, M.J.5
Gjerset, R.6
Mercola, D.7
-
10
-
-
3042748279
-
Downregulation of survivin gene expression by RNAi knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells
-
Konnikova L, Kotecki M, Kruger MM, Cochran BH and Miao GY: Downregulation of survivin gene expression by RNAi knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 3: 23, 2003.
-
(2003)
BMC Cancer
, vol.3
, pp. 23
-
-
Konnikova, L.1
Kotecki, M.2
Kruger, M.M.3
Cochran, B.H.4
Miao, G.Y.5
-
11
-
-
34547134721
-
Suppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAs
-
Sioud M, Furset G and Cekaite L: Suppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAs. Biochem Biophys Res Commun 361: 122-126, 2007.
-
(2007)
Biochem Biophys Res Commun
, vol.361
, pp. 122-126
-
-
Sioud, M.1
Furset, G.2
Cekaite, L.3
-
12
-
-
6044248871
-
Therapeutic potential of RNA interference
-
Stevenson M: Therapeutic potential of RNA interference. Engl J Med 351: 1772-1777, 2004.
-
(2004)
Engl J Med
, vol.351
, pp. 1772-1777
-
-
Stevenson, M.1
-
14
-
-
70449363841
-
Downregulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3
-
Parra E, Ortega A and Saenz L: Downregulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3. Oncol Rep 22: 1513-1518, 2009.
-
(2009)
Oncol Rep
, vol.22
, pp. 1513-1518
-
-
Parra, E.1
Ortega, A.2
Saenz, L.3
-
15
-
-
77949474627
-
The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines
-
Parra E and Ferreira J: The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines. Oncol Rep 22: 1159-1165, 2010.
-
(2010)
Oncol Rep
, vol.22
, pp. 1159-1165
-
-
Parra, E.1
Ferreira, J.2
-
16
-
-
0347623204
-
Non-specific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNA)
-
Persengiev SP, Zhu X and Green MR: Non-specific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNA). RNA 10: 12-18, 2004.
-
(2004)
RNA
, vol.10
, pp. 12-18
-
-
Persengiev, S.P.1
Zhu, X.2
Green, M.R.3
-
17
-
-
0037117550
-
A DNA vector based RNAi technology to suppress gene expression in mammalian cells
-
Sui G, Soohoo C, Affar E, Gay F, Shi Y, Forrester WC and Shi Y: A DNA vector based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 99: 5515-5520, 2002.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 5515-5520
-
-
Sui, G.1
Soohoo, C.2
Affar, E.3
Gay, F.4
Shi, Y.5
Forrester, W.C.6
Shi, Y.7
-
18
-
-
0030998713
-
Induction of apoptosis by the transcription factor c-Jun
-
Bossy-Wetzel E, Bakiri L and Yaniv M: Induction of apoptosis by the transcription factor c-Jun. EMBO J 16: 1695-1709, 1997.
-
(1997)
EMBO J
, vol.16
, pp. 1695-1709
-
-
Bossy-Wetzel, E.1
Bakiri, L.2
Yaniv, M.3
-
19
-
-
42249085983
-
Opposing regulation of T cell function by Egr-1/ NAB2 and Egr-2/Egr-3
-
Collins S, Lutz MA, Zank PA, Anders R, Kersh G and Powell JD: Opposing regulation of T cell function by Egr-1/ NAB2 and Egr-2/Egr-3. Eur J Immunol 38: 528-536, 2008.
-
(2008)
Eur J Immunol
, vol.38
, pp. 528-536
-
-
Collins, S.1
Lutz, M.A.2
Zank, P.A.3
Anders, R.4
Kersh, G.5
Powell, J.D.6
-
20
-
-
0036328973
-
Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells
-
Amorino G, Hamilton V, Valerie K, Dent P, Lammering G and Schmidt-Ullrich R: Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Mol Biol Cell 13: 2233-2244, 2002.
-
(2002)
Mol Biol Cell
, vol.13
, pp. 2233-2244
-
-
Amorino, G.1
Hamilton, V.2
Valerie, K.3
Dent, P.4
Lammering, G.5
Schmidt-Ullrich, R.6
-
21
-
-
27544444555
-
Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity
-
Inostroza J, Saenz L, Calaf G, Cabello G and Parra E: Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity. Biol Res 38: 163-178, 2005.
-
(2005)
Biol Res
, vol.38
, pp. 163-178
-
-
Inostroza, J.1
Saenz, L.2
Calaf, G.3
Cabello, G.4
Parra, E.5
-
22
-
-
0034650759
-
A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells
-
Xiao L and Lang WA: A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. Cancer Res 60: 400-408, 2000.
-
(2000)
Cancer Res
, vol.60
, pp. 400-408
-
-
Xiao, L.1
Lang, W.A.2
-
23
-
-
0032507971
-
Transition from SCLC to NSVLC phenotype is accompanied by an increased TRE-binding acticity and recruitment of specific AP-1 proteins
-
Risse-Hackl G, Adamkiewicz J, Wimmel A and Schuermann M: Transition from SCLC to NSVLC phenotype is accompanied by an increased TRE-binding acticity and recruitment of specific AP-1 proteins. Oncogene 16: 3057-3068, 1998.
-
(1998)
Oncogene
, vol.16
, pp. 3057-3068
-
-
Risse-Hackl, G.1
Adamkiewicz, J.2
Wimmel, A.3
Schuermann, M.4
-
24
-
-
0031453248
-
The JUN kinase/ stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells
-
Bost F, McKay R, Dean N and Mercola D: The JUN kinase/ stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J Biol Chem 272: 33422-33429, 1997.
-
(1997)
J Biol Chem
, vol.272
, pp. 33422-33429
-
-
Bost, F.1
McKay, R.2
Dean, N.3
Mercola, D.4
-
25
-
-
0034637575
-
c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells
-
Potapova O, Gorospe M, Bost F, Dean NM, Gaarde W, Mercola D and Holbrook N: c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J Biol Chem 275: 24767-24775, 2000.
-
(2000)
J Biol Chem
, vol.275
, pp. 24767-24775
-
-
Potapova, O.1
Gorospe, M.2
Bost, F.3
Dean, N.M.4
Gaarde, W.5
Mercola, D.6
Holbrook, N.7
-
27
-
-
0031060238
-
DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines
-
Delmastro DA, Li V, Vaisman A, Solle M and Charney SG: DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 39: 245-253, 1997.
-
(1997)
Cancer Chemother Pharmacol
, vol.39
, pp. 245-253
-
-
Delmastro, D.A.1
Li, V.2
Vaisman, A.3
Solle, M.4
Charney, S.G.5
-
28
-
-
0033841622
-
Molecular mechanisms involved in cisplatin cytotoxicity
-
Jordan P and Carmo-Fonseca M: Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci 57: 1229-1235, 2000.
-
(2000)
Cell Mol Life Sci
, vol.57
, pp. 1229-1235
-
-
Jordan, P.1
Carmo-Fonseca, M.2
-
29
-
-
0032949934
-
Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: Inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin
-
Persons DL, Yazlovitskaya EM, Cul W and Pelling JC: Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res 5: 1007-1014, 1999.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 1007-1014
-
-
Persons, D.L.1
Yazlovitskaya, E.M.2
Cul, W.3
Pelling, J.C.4
-
30
-
-
0035958870
-
Protective role for c-Jun in the cellular response to DNA damage
-
Potapova O, Basu S, Mercola D and Holbrook NJ: Protective role for c-Jun in the cellular response to DNA damage. J Biol Chem 276: 28546-28553, 2001.
-
(2001)
J Biol Chem
, vol.276
, pp. 28546-28553
-
-
Potapova, O.1
Basu, S.2
Mercola, D.3
Holbrook, N.J.4
-
31
-
-
0025788098
-
Oncogenic and transcriptional cooperation with Ha-Ras requires phosphoryaltion of c-Jun on serines 63 and 73
-
Smeal T, Binetruy B, Mercola D, Birrer M and Karin M: Oncogenic and transcriptional cooperation with Ha-Ras requires phosphoryaltion of c-Jun on serines 63 and 73. Nature 354: 494-496, 1991.
-
(1991)
Nature
, vol.354
, pp. 494-496
-
-
Smeal, T.1
Binetruy, B.2
Mercola, D.3
Birrer, M.4
Karin, M.5
-
32
-
-
12644272789
-
Tumor necrosis factor (TNF) mediated kinase cascades: Bifurcation of nuclear factor kappa B and c jun N terminal kinase (JNK/SAPK) pathways at TNF receptor associated factor 2
-
Song HY, Rognier CH, Kirschning CJ, Goeddel DV and Rothe M: Tumor necrosis factor (TNF) mediated kinase cascades: bifurcation of nuclear factor kappa B and c jun N terminal kinase (JNK/SAPK) pathways at TNF receptor associated factor 2. Proc Natl Acad Sci USA 94: 9792-9796, 1997.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 9792-9796
-
-
Song, H.Y.1
Rognier, C.H.2
Kirschning, C.J.3
Goeddel, D.V.4
Rothe, M.5
-
33
-
-
0030927326
-
Activation of the JNK pathway is essential for transformation by the Met oncogene
-
Rodrigues GA, Park M and Schlissinger J: Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J 16: 2634-2645, 1997.
-
(1997)
EMBO J
, vol.16
, pp. 2634-2645
-
-
Rodrigues, G.A.1
Park, M.2
Schlissinger, J.3
-
34
-
-
0032579405
-
Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor
-
Antonyak MA, Moscatello D and Wong A: Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor. J Biol Chem 273: 2817-2822, 1998.
-
(1998)
J Biol Chem
, vol.273
, pp. 2817-2822
-
-
Antonyak, M.A.1
Moscatello, D.2
Wong, A.3
-
35
-
-
0030840413
-
Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway
-
Logan S, Falasca M, Hu P and Schlessinger J: Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway. Mol Cell Biol 7: 5784-5789, 1997.
-
(1997)
Mol Cell Biol
, vol.7
, pp. 5784-5789
-
-
Logan, S.1
Falasca, M.2
Hu, P.3
Schlessinger, J.4
-
36
-
-
0029070887
-
Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs
-
Minden A, Lin A, Claret FX, Abo A and Karin M: Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81: 1147-1157, 1995.
-
(1995)
Cell
, vol.81
, pp. 1147-1157
-
-
Minden, A.1
Lin, A.2
Claret, F.X.3
Abo, A.4
Karin, M.5
-
37
-
-
0033615657
-
Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell-line
-
Hayakawa J, Ohmichi M, Kurach H, Ikegami H, Kimura A, Matsuoka T, Jikihara H, Mercola D and Murata Y: Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell-line. J Biol Chem 274: 31648-31654, 1999.
-
(1999)
J Biol Chem
, vol.274
, pp. 31648-31654
-
-
Hayakawa, J.1
Ohmichi, M.2
Kurach, H.3
Ikegami, H.4
Kimura, A.5
Matsuoka, T.6
Jikihara, H.7
Mercola, D.8
Murata, Y.9
-
38
-
-
0037237136
-
C-Jun NH2-terminal kinase mediates proliferation and tumor growth in human prostrate carcinoma
-
Yong-Min Y, Bost F, Charbono W, Dean N, McKay R, Depatie C and Mercola D: C-Jun NH2-terminal kinase mediates proliferation and tumor growth in human prostrate carcinoma. Clin Cancer Res 9: 391-401, 2003.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 391-401
-
-
Yong-Min, Y.1
Bost, F.2
Charbono, W.3
Dean, N.4
McKay, R.5
Depatie, C.6
Mercola, D.7
-
39
-
-
0038757747
-
The stress response of Jun kinase to DNA-damaging drugs serves to promote drug resistance via phospho-ATF2-dependent DNA repair
-
Hayakawa J, Depatie C, Ohmichi M and Mercola D: The stress response of Jun kinase to DNA-damaging drugs serves to promote drug resistance via phospho-ATF2-dependent DNA repair. J Biol Chem 278: 20582-20592, 2003.
-
(2003)
J Biol Chem
, vol.278
, pp. 20582-20592
-
-
Hayakawa, J.1
Depatie, C.2
Ohmichi, M.3
Mercola, D.4
-
40
-
-
17144365869
-
Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks
-
Banerjee S, Sengupta K, Saxena NK, Dhar K and Banerjee SK: Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks. Mol Cancer Res 3: 151-159, 2005.
-
(2005)
Mol Cancer Res
, vol.3
, pp. 151-159
-
-
Banerjee, S.1
Sengupta, K.2
Saxena, N.K.3
Dhar, K.4
Banerjee, S.K.5
-
41
-
-
0029929510
-
Activation and inhibition of the AP-1 complex in human breast cancer cells
-
Chen TK, Smith LM, Gebhardt DK, Birrer M and Brown PH: Activation and inhibition of the AP-1 complex in human breast cancer cells. Mol Carcinog 15: 215-226, 1996.
-
(1996)
Mol Carcinog
, vol.15
, pp. 215-226
-
-
Chen, T.K.1
Smith, L.M.2
Gebhardt, D.K.3
Birrer, M.4
Brown, P.H.5
-
42
-
-
0038757747
-
The activation of c-Jun NH2-terminal kinase (JNK) by DNAdamaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair
-
Hayakawa J, Depatie C, Ohmichi M and Mercola D: The activation of c-Jun NH2-terminal kinase (JNK) by DNAdamaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. J Biol Chem 278: 20582-20592, 2003.
-
(2003)
J Biol Chem
, vol.278
, pp. 20582-20592
-
-
Hayakawa, J.1
Depatie, C.2
Ohmichi, M.3
Mercola, D.4
-
43
-
-
0028971259
-
jun-NH2-terminal kinase activation mediated by UVinduced DNA lesions in melanoma and fibroblast cells
-
Adler V, Fuchs S, Kim J, Kraft A, King MP, Pelling J and Ronai Z: jun-NH2-terminal kinase activation mediated by UVinduced DNA lesions in melanoma and fibroblast cells. Cell Growth Differ 6: 1437-1446, 1995.
-
(1995)
Cell Growth Differ
, vol.6
, pp. 1437-1446
-
-
Adler, V.1
Fuchs, S.2
Kim, J.3
Kraft, A.4
King, M.P.5
Pelling, J.6
Ronai, Z.7
-
44
-
-
0034465670
-
Insulin-like growth factor I activates c-Jun N-terminal kinase in MCF-7 breast cancer cells
-
Monno S, Newman MV, Cook M and Lowe WL: Insulin-like growth factor I activates c-Jun N-terminal kinase in MCF-7 breast cancer cells. Endocrinology 141: 544-550, 2000.
-
(2000)
Endocrinology
, vol.141
, pp. 544-550
-
-
Monno, S.1
Newman, M.V.2
Cook, M.3
Lowe, W.L.4
-
45
-
-
0033499801
-
BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M
-
Yamamoto K, Ichijo H and Korsmeyer SJ: BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19: 8469-8478, 1999.
-
(1999)
Mol Cell Biol
, vol.19
, pp. 8469-8478
-
-
Yamamoto, K.1
Ichijo, H.2
Korsmeyer, S.J.3
|